𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Detection and identification of tumor-associated protein variants in human hepatocellular carcinomas

✍ Scribed by Evelyn Zeindl-Eberhart; Sibylle Haraida; Sibylle Liebmann; Peter Roman Jungblut; Stephanie Lamer; Doris Mayer; Gundula Jäger; Stephen Chung; Hartmut Manfred Rabes

Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
402 KB
Volume
39
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

✦ Synopsis

The proteomic approach is a valuable tool to detect and identify proteins that are associated with cancer. In previous investigations on experimentally induced rat hepatomas, we detected aldose reductase-like protein (ARLP) as a highly significant marker protein. Our present study was intended to look for the presence of similar tumor-associated marker proteins on human hepatocellular carcinomas (HCC). We found several novel tumor-associated protein variants that represent members of the aldo-keto reductase (AKR) superfamily. Human aldose reductase-like protein-1 (hARLP-1) was the most prominent tumor-associated AKR member detected in HCC by 2-dimensional electrophoresis (2-DE) and identified by mass spectrometric fingerprinting. The enzyme was found in 4 distinct forms (hARLP-1, 36/7.4 (kd/pI); hARLP-2, 36/7.2; hARLP-3, 36/6.4; and hARLP-4, 33/7.35). In addition, a human aldose reductase-like protein (hARLP-5, 36/7.6) was identified that differed from hARLP-1 by 1 amino acid (D313N), indicating 2 allelic forms of the human aldose reductase-like gene. A novel antibody directed against common parts of the hARLPs revealed hARLP reactivity in human HCC by immunohistochemistry. Furthermore, aldose reductase (AR) was identified and characterized as a tumor-associated variant. In conclusion, in all investigated human HCCs at least one of the various types of the described tumor-associated proteins of the AKR superfamily was clearly present. Of these HCC samples, 95% were positive for hARLPs as proven by 2-DE analysis and/or by use of the antibody directed against hARLP. Thus, hARLP is a strong candidate for use as an immunohistochemical diagnostic marker of human HCC.

📜 SIMILAR VOLUMES

Identification of variants in NFKBIA and
Identification of variants in NFKBIA and association analysis with hepatocellular carcinoma risk among chronic HBV patients
✍ Lyoung Hyo Kim; Hyoung Doo Shin; Byung Lae Park; Ji Hyun Jung; Jun Yeun Kim; Yoo 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB 👁 2 views

Human nuclear factor of kappa light chain gene enhancer in B cells inhibitor, alpha (NFKBIA) inhibits the action of NF-κB by forming a heterodimer with NF-κB, and preventing its translocation to the nucleus. We have sequenced a human NFKBIA full gene including -1000bp promoter region to identify its

Over-expression and lack of retinoblasto
Over-expression and lack of retinoblastoma protein are associated with tumor progression and metastasis in hepatocellular carcinoma
✍ Ai-Min Hui; Xin Li; Masatoshi Makuuchi,; Tadatoshi Takayama; Keiichi Kubota 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 352 KB 👁 2 views

To determine the role of retinoblastoma (Rb) gene alteration in hepatocarcinogenesis, we examined Rb protein expression immuno-histochemically in a series of surgically resected specimens including non-cancerous liver tissues with cirrhosis or chronic hepatitis, large regenerative nodules, pre-cance

Decreased expression of p27 protein is a
Decreased expression of p27 protein is associated with advanced tumor stage in hepatocellular carcinoma
✍ Andrea Tannapfel; Dorothee Grund; Alexander Katalinic; Dirk Uhlmann; Ferdinand K 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 217 KB 👁 2 views

Reduced expression of the cyclin-dependent kinase inhibitor p27 has previously been correlated with fatal clinical outcome in some tumors, including gastric, breast, and prostate cancers. For hepatocellular carcinoma, the findings are equivocal. In situ hybridization and immunohistochemistry were pe